The Scientific Advisory Team at SiteOne Therapeutics provides expert guidance on the research and development of therapeutics targeting hypersensitivity disorders. Comprising seasoned scientific advisors and researchers, the team collaborates to oversee experimental design, optimize drug candidate selection, and ensures that scientific strategies align with clinical goals and regulatory standards.
Anthony Ford
Scientific Advisor
Bradley J. Undem
Scientific Advisor
Brendan Canning
Scientific Advisor
Frank Porreca
Scientific Advisor
Gary D. Novack
Scientific Advisor
Jie (Jackson) Zhu
Senior Research Scientist, Che...
Michael C. Rowbotham
Scientific Advisor
Peter Dicpinigaitis
Scientific Advisor
Stephen G. Waxman
Scientific Advisor
Stephen Wexler
Scientific Advisor
View all